Effect of cortex mori on pharmacokinetic profiles of main isoflavonoids from pueraria lobata in rat plasma

Add time:09/02/2019    Source:sciencedirect.com

Ethnopharmacological relevanceRadix pueraria (the root of pueraria lobata (Wild.) Ohwi.), which contains a class of isoflavonoids as the main active components, as well as cortex mori (the root bark of Morus alba L), which contains abundant active alkaloids, have been employed for the treatment of diabetes in traditional Chinese medicine for centuries. In previous studies, pharmacodynamic synergistic reactions have been observed in compatible application of pueraria lobata isoflavonoids extracts (PLF) and cortex mori alkaloids extracts (CME) for inhibiting α-glycosidase activity. It has also been demonstrated that PLF can effectively slow down the absorption of active alkaloid from CME, so as to produce a higher effective concentration in small intestine for depressing the elevation of postprandial blood glucose through inhibiting α-glycosidase activity.

We also recommend Trading Suppliers and Manufacturers of Pueraria glycoside (cas 117060-54-5). Pls Click Website Link as below: cas 117060-54-5 suppliers

Prev:Pharmacokinetic profiles of the five isoflavonoids from Pueraria lobata roots in the CSF and plasma of rats
Next:Analytical MethodsOptimisation of Pueraria isoflavonoids by response surface methodology using ultrasonic-assisted extraction)